ISI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ionis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 67.36 EUR Market Closed

Market Cap: €5.9B

I	Ionis Pharmaceuticals Inc XBER:ISI	US
	HCA Healthcare Inc NYSE:HCA	US
	China Citic Bank Corp Ltd F:D7C	CN

Profitability Summary

Ionis Pharmaceuticals Inc's profitability score is 27/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Declining Gross Margin

99% > 98%

Negative Operating Margin

-68%

Negative 3Y Average Operating Margin

-50%

Operating Margin is Increasing

-75% > -68%

Negative Net Margin

-65%

Negative 3Y Average Net Margin

-48%

Declining Net Margin

-49% > -65%

Negative Free Cash Flow Margin

-64%

Negative 3Y Average Free Cash Flow Margin

-56%

Free Cash Flow Margin is Increasing

-77% > -64%

Negative ROE

-105%

Negative 3Y Average ROE

Positive 3Y Average ROIC

22%

ROIC is Increasing

-105% > -76%

View All

Hide

Collapse

27 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.